~~<i id='BEA830732E'><strike id='BEA830732E'><tt id='BEA830732E'><pre id='BEA830732E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：explore 2025-10-01 23:02:07 - browse：3639

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Johnson & Johnson sues to stop Medicare negotiation

entertainment

explore

hotspot

leisure time

explore

hotspot

Sen.JohnThuneisoneofagroupoflawmakersthatisworkingon340Breformlegislation.BRENDANSMIALOWSKI/AFPviaGe

WSS

US soldier in North Korean custody after crossing DMZ line

Johnson & Johnson sued for allegedly overpaying for workers' drugs

A look at other Americans who have crossed into North Korea over the years

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Cano Health’s bankruptcy is a warning for Medicare Advantage

Problems with a popular proposal to regulate AI in health care

explore

hotspot

entertainment

Walensky prepares to leave CDC — and Congress — behind

The Biogen Aduhelm mess could happen again

Jerome Adams on the need for new antivirals for Covid

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Medical leaders decry Supreme Court decision on affirmative action

Johnson & Johnson sues to stop Medicare negotiation

Medicare details structure of new drug price negotiation program

Global cancer cases to surge 77% by 2050, WHO report says

23andMe had bad news about my health. I wish a person had delivered it

ER docs worry over extreme heat as a 'mass casualty event'

explore

Lack of darker skin in textbooks, journals harms patients of color

Readout LOUD: Venture capital, Gilead, and more M&A

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Readout LOUD: Venture capital, Gilead, and more M&A

Lack of darker skin in textbooks, journals harms patients of color

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

hotspot

leisure time

explore

hotspot